A series of practical case studies, interactive roundtables and panel discussion facilitated by leading industry experts will provide executives with useful tools and best practices to:• Explore the use of adaptive design methods in clinical trials• Adapt clinical development for immunotherapies in oncology• Evaluate adaptive designs and Bayesian statistic• Improve covariant adaptive designs• Seamless Phase I/II Dose Finding Designs with Efficacy and Safety EndpointsKeynote speakers include:Bo Huang, Director of Biostatistics, Pfizer USAAlex Sverdlov, Associate Director of Biostatistics, EMD SeronoLoïc Darchy, Head of Statistical Methodology Group, Sanofi R&DPhilip Hougaard, Vice President, Biometrics, Lundbeck A/SGiacomo Mordenti, Senior Director, Head of Biostatistics, GrunenthalBruce Turnbull, Professor of Statistics, Cornell University